Article

REVEL is better at predicting pathogenicity of loss-of-function than gain-of-function variants

2023-06-07

Abstract excerpt

In silico predictive tools can help determine the pathogenicity of variants. The 2015 American College of Medical Genetics and Genomics (ACMG) guidelines recommended that scores from these tools can be used as supporting evidence of pathogenicity. A subsequent publication by the ClinGen Sequence Variant Interpretation Working Group suggested high scores from some tools were sufficiently predictive to be used as mo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f1132d72-b3b4-5b7f-851f-2282abf3ff22
DOI: 10.1101/2023.06.06.23290963

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

REVEL is better at predicting pathogenicity of loss-of-function than gain-of-function variantsDOI 10.1101/2023.06.06.23290963Read

REVEL Is Better at Predicting Pathogenicity of Loss-of-Function than Gain-of-Function VariantsSemantic proximity Read

A New Era in Missense Variant Analysis: Statistical Insights and the Introduction of VAMPP-Score for Pathogenicity AssessmentSemantic proximity Read

Assessing the performance of 28 pathogenicity prediction methods on rare single nucleotide variants in coding regions.Semantic proximity Read

A curated census of pathogenic and likely pathogenic UTR variants and evaluation of deep learning models for variant effect predictionSemantic proximity Read

Evaluating novel in silico tools for accurate pathogenicity classification in epilepsy-associated genetic missense variants.Semantic proximity Read

GLOF: A large-scale expert-curated benchmark dataset of gain-of-function and loss-of-function missense variantsSemantic proximity Read

REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsSemantic proximity Read

Refinement of the clinical variant interpretation framework by statistical evidence and machine learning.Semantic proximity Read

Assessing performance of pathogenicity predictors using clinically-relevant variant datasetsSemantic proximity Read

Prevalence of loss-of-function, gain-of-function and dominant-negative mechanisms across genetic disease phenotypesSemantic proximity Read

Incorporation of clinical and molecular variant properties improves the performance of in silico pathogenicity prediction tools.Semantic proximity Read

Evaluation of<i>in silico</i>pathogenicity prediction tools for the classification of small in-frame indelsSemantic proximity Read